These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
27. [The cause of failure of eradication treatment of Helicobacter pylori]. Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353 [TBL] [Abstract][Full Text] [Related]
28. Eradication therapy for Helicobacter pylori. Vakil N; Megraud F Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602 [TBL] [Abstract][Full Text] [Related]
29. [Helicobacter pylori infection: what to do after first intent treatment failure?]. Delchier JC Rev Prat; 2008 Sep; 58(13):1442-4. PubMed ID: 18924328 [TBL] [Abstract][Full Text] [Related]
30. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients. Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050 [TBL] [Abstract][Full Text] [Related]
31. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444 [TBL] [Abstract][Full Text] [Related]
33. 13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population. Gal E; Abuksis G; Fraser G; Koren R; Shmueli C; Yahav Y; Niv Y Isr Med Assoc J; 2003 Feb; 5(2):98-100. PubMed ID: 12674657 [TBL] [Abstract][Full Text] [Related]
35. Rescue therapy with levofloxacin after multiple H. pylori treatment failures. Gisbert JP Aliment Pharmacol Ther; 2005 Oct; 22(7):653-4; author reply 654-5. PubMed ID: 16181305 [No Abstract] [Full Text] [Related]
36. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. Buzás GM; Józan J Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530 [TBL] [Abstract][Full Text] [Related]
37. [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura]. Takahashi T; Hatao K; Yamada K Rinsho Ketsueki; 2006 May; 47(5):392-5. PubMed ID: 16784096 [TBL] [Abstract][Full Text] [Related]
38. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844 [TBL] [Abstract][Full Text] [Related]
39. Primary and secondary treatment for Helicobacter pylori in the United States. Vakil N Rev Gastroenterol Disord; 2005; 5(2):67-72. PubMed ID: 15976737 [TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection in children: management and pharmacotherapy. Sabbi T; De Angelis P; Dall'Oglio L Expert Opin Pharmacother; 2008 Mar; 9(4):577-85. PubMed ID: 18312159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]